Cited by 1,676Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerFerroptosis and cancer prognosis

The DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.

Hypoxia signalling in cancer and approaches to enforce tumour regression

Pouysségur, Jacques, Dayan, Frédéric, Mazure, Nathalie M.·2006·Nature

Open this paper in CoChat — free account

Abstract

Tumour cells emerge as a result of genetic alteration of signal circuitries promoting cell growth and survival, whereas their expansion relies on nutrient supply. Oxygen limitation is central in controlling neovascularization, glucose metabolism, survival and tumour spread. This pleiotropic action is orchestrated by hypoxia-inducible factor (HIF), which is a master transcriptional factor in nutrient stress signalling. Understanding the role of HIF in intracellular pH (pH(i)) regulation, metabolism, cell invasion, autophagy and cell death is crucial for developing novel anticancer therapies. There are new approaches to enforce necrotic cell death and tumour regression by targeting tumour metabolism and pH(i)-control systems.

Integrity signals

Registry

Crossref · 10.1038/nature04871

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,661
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653

Flagged first, then by citations

Show all 104 references

1 of the 104 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 1,002

Systemic Overexpression of Angiopoietin-2 Promotes Tumor Microvessel Regression and Inhibits Angiogenesis and Tumor Growth
Cao, Y., Sonveaux, P., Liu, S., Zhao, Y., Mi, J., Clary, B. M., Li, C., Kontos, C. D., & Dewhirst, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4056 · Cited by 101
Imaging tumor hypoxia by magnetic resonance methods
Pacheco‐Torres, J., López‐Larrubia, P., Ballesteros, P., & Cerdán, S. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1558 · Cited by 99
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series ofin vitrobreast cancer models
Ward, C., Meehan, J., Mullen, P., Supuran, C. T., Dixon, J. M., Thomas, J. S. J., Winum, J., Lambin, P., Dubois, L. J., Pavathaneni, N.-K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4498 · Cited by 99
Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma
Chaumeil, M. M., Ozawa, T., Park, I., Scott, K., James, C. D., Nelson, S. J., & Ronen, S. M. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.034 · Cited by 96
Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
Carbonaro, M., O’Brate, A., & Giannakakou, P. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201004145 · Cited by 95
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
Zalfa, C., & Paust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633205 · Cited by 100
Design of Clinical Trials of Radiation Combined with Antiangiogenic Therapy
Senan, S., & Smit, E. F. (2007) · The Oncologist · doi:10.1634/theoncologist.12-4-465 · Cited by 95
Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma
Venkatesh, H. S., Chaumeil, M. M., Ward, C. S., Haas-Kogan, D. A., James, C. D., & Ronen, S. M. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor209 · Cited by 94
STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma
Zhao, H., Yan, G., Zheng, L., Zhou, Y. J., Sheng, H., Wu, L., Zhang, Q., Lei, J., Zhang, J., Xin, R., et al. (2020) · Theranostics · doi:10.7150/thno.44025 · Cited by 97
Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site
Matthew, S., Chen, Q.-Y., Ratnayake, R., Fermaintt, C. S., Lucena‐Agell, D., Bonato, F., Prota, A. E., Lim, S. T., Wang, X., Díaz, J. F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021847118 · Cited by 94
Characterization of the tumor microenvironment and tumor–stroma interaction by non-invasive preclinical imaging
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
Undernutrition in elderly patients with cancer: Target for diagnosis and intervention
Blanc-Bisson, C., Fonck, M., Rainfray, M., Soubeyran, P., & Bourdel‐Marchasson, I. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.04.005 · Cited by 93
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells
Zeng, L., Chen, Y., Huang, H., Wang, J., Zhao, D., Ji, L., & Chao, H. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502154 · Cited by 94
Primary Cilium in Cancer Hallmarks
Fabbri, L., Bost, F., & Mazure, N. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061336 · Cited by 93
Self-citation
Multifunctional nanoparticles as photosensitizer delivery carriers for enhanced photodynamic cancer therapy
Zhang, Y., Wang, B., Zhao, R., Zhang, Q., & Kong, X. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111099 · Cited by 95
Metabolomics In Biomarker Discovery: Future Uses For Cancer Prevention
Kim, Y. S., Maruvada, P., & Milner, J. A. (2008) · Future Oncology · doi:10.2217/14796694.4.1.93 · Cited by 93
A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment
Dayan, F., Mazure, N. M., Brahimi-Horn, M. C., & Pouysségur, J. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0006-3 · Cited by 96
Self-citation
Evolving role of adiponectin in cancer-controversies and update
Katira, A., Katira, A., Tan, P., & Tan, P. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2015.0092 · Cited by 95
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
Spinella, F., Rosanò, L., Castro, V. D., Decandia, S., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2606 · Cited by 96
Microenvironmental influences in melanoma progression
Lee, J. T., & Herlyn, M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21204 · Cited by 99
Current developments of macrophage migration inhibitory factor (MIF) inhibitors
Xu, L., Li, Y., Sun, H., Zhen, X., Qiao, C., Tian, S., & Hou, T. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.013 · Cited by 92
Control of ovulation in mice by progesterone receptor-regulated gene networks
Kim, J., Bagchi, I. C., & Bagchi, M. K. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap082 · Cited by 92
The biology and the genetics of Hürthle cell tumors of the thyroid
Máximo, V., Lima, J. P., Prazeres, H., Soares, P., & Sobrinho-Simões, M. A. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0354 · Cited by 93
Disrupting the ‘Warburg effect’ re-routes cancer cells to OXPHOS offering a vulnerability point via ‘ferroptosis’-induced cell death
Ždralević, M., Vučetić, M., Daher, B., Marchiq, I., Parks, S. K., & Pouysségur, J. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.12.002 · Cited by 93
Self-citation
Na+/K+-ATPase Revisited: On Its Mechanism of Action, Role in Cancer, and Activity Modulation
Bejček, J., Spiwok, V., Kmonı́čková, E., & Rimpelová, S. (2021) · Molecules · doi:10.3390/molecules26071905 · Cited by 96
Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia
Bonnin, D. A. A., Havrda, M. C., Lee, M. C., Liu, H., Zhang, Z., Nguyen, L., Harrington, L. X., Hassanpour, S., Cheng, C., & Israel, M. A. (2017) · Oncogene · doi:10.1038/onc.2017.404 · Cited by 95
Regulators of glucose uptake in thyroid cancer cell lines
Heydarzadeh, S., Moshtaghie, A. A., Daneshpoor, M. S., & Hedayati, M. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00586-x · Cited by 95
Loss of epidermal hypoxia-inducible factor-1α accelerates epidermal aging and affects re-epithelialization in human and mouse
Rezvani, H. R., Ali, N., Serrano-Sanchez, M., Dubus, P., Varon, C., Ged, C., Pain, C., Cario-André, M., Seneschal, J., Taïeb, A., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.082370 · Cited by 90
HIV Protease Inhibitors Decrease VEGF/HIF-1α Expression and Angiogenesis in Glioblastoma Cells
Pore, N., Gupta, A., Cerniglia, G. J., & Maity, A. M. (2006) · Neoplasia · doi:10.1593/neo.06535 · Cited by 88
FGF2 Translationally Induced by Hypoxia Is Involved in Negative and Positive Feedback Loops with HIF-1α
Conte, C., Riant, É., Toutain, C. E., Pujol, F., Arnal, J., Lenfant, F., & Prats, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003078 · Cited by 95
Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase‐facilitated breast cancer migration
Postovit, L.-M. M., Abbott, D. E., Raimondi, S. L., Wheaton, W. W., Margaryan, N. V., Sullivan, R., Jansen, M. K., Csiszár, K., Hendrix, M. J. C., & Kirschmann, D. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21517 · Cited by 88
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 92
Analysis of hypoxia-associated gene expression in prostate cancer: lysyl oxidase and glucose transporter-1 expression correlate with Gleason score
Stewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89
Cell death mechanisms: Cross-talk and role in disease
Zhivotovsky, B., & Orrenius, S. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.037 · Cited by 90
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
Greenhough, A., Bagley, C., Heesom, K. J., Gurevich, D., Gay, D. M., Bond, M., Collard, T. J., Paraskeva, C., Martin, P. B., Sansom, O. J., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708699 · Cited by 88
The long and winding road of cardiomyocyte maturation
Maroli, G., & Braun, T. W. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa159 · Cited by 89
Expression of hypoxia-inducible factor−1α and −2α in human choroidal neovascular membranes
Sheridan, C., Pate, S., Hiscott, P. S., Wong, D., Pattwell, D. M., & Kent, D. L. (2009) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-009-1133-3 · Cited by 88
The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target
Icard, P., & Lincet, H. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.003 · Cited by 86
Novel Drugs with High Efficacy against Tumor Angiogenesis
Qi, S., Deng, S., Lian, Z., & Yu, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136934 · Cited by 88
Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells
Cho, S., Lee, H., Jeong, S., Lee, H., Kim, H., Chen, C. Y., Lee, E., & Kim, S. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00865.x · Cited by 86
Light-Enhanced Hypoxia-Response of Conjugated Polymer Nanocarrier for Successive Synergistic Photodynamic and Chemo-Therapy
Zhang, X., Wu, M., Li, J., Lan, S., Zeng, Y., Liu, X., & Liu, J. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b06491 · Cited by 86
HIF‐1α: coordinates lymphangiogenesis during wound healing and in response to inflammation
Zampell, J. C., Yan, A., Avraham, T., Daluvoy, S. V., Weitman, E. S., & Mehrara, B. J. (2011) · The FASEB Journal · doi:10.1096/fj.11-195321 · Cited by 86
Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway
Li, W., Cao, L., Chen, X., Lei, J., & Ma, Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4504 · Cited by 85
Diabetic nephropathy: a disorder of oxygen metabolism?
Miyata, T., & de Strihou, C. V. Y. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.211 · Cited by 82
Oxygenation of the placental–fetal unit in humans
Schneider, H. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.05.009 · Cited by 84
Every Breath You Take: Non-invasive Real-Time Oxygen Biosensing in Two- and Three-Dimensional Microfluidic Cell Models
Zirath, H., Rothbauer, M., Spitz, S., Bachmann, B., Jordan, C., Müller, B., Ehgartner, J., Priglinger, E., Mühleder, S., Redl, H. R., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00815 · Cited by 83
The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression
Bernard, H., Garmy-Susini, B. H., Ainaoui, N., Berghe, L. V. D., Peurichard, A., Javerzat, S., Bikfalvi, A., Lane, D. P., Bourdon, J., & Prats, A. (2012) · Oncogene · doi:10.1038/onc.2012.242 · Cited by 83
Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence
Crawford, S. (2014) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834014521111 · Cited by 86
NFκB and HIF display synergistic behaviour during hypoxic inflammation
Brüning, U., Fitzpatrick, S. F., Frank, T. D., Birtwistle, M. R., Taylor, C. T., & Cheong, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0876-2 · Cited by 85
Metabolic remodeling in early development and cardiomyocyte maturation
Kreipke, R. E., Wang, Y., Miklas, J. W., Mathieu, J., & Ruohola‐Baker, H. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.02.004 · Cited by 85
Synthesis, biological evaluation, molecular docking and DFT calculations of novel benzenesulfonamide derivatives
Fahim, A. M., & Shalaby, M. A. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.08.087 · Cited by 83
Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma
Bhuria, V., Xing, J., Scholta, T., Bùi, K. C., Nguyen, M. L. T., Malek, N. P., Bozko, P. M., & Plentz, R. R. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111671 · Cited by 83
Aging and Inflammation: Etiological Culprits of Cancer
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., Majumdar, A. P. N., & Sarkar, F. H. (2009) · Current Aging Science · doi:10.2174/1874609810902030174 · Cited by 83
RETRACTED ARTICLE: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
Khandrika, L., Lieberman, R., Koul, S., Kumar, B., MARONI, P. D., Chandhoke, R. A., Meacham, R. B., & Koul, H. K. (2009) · Oncogene · doi:10.1038/onc.2008.476 · Cited by 84
Retracted
Inhibition of Prolyl Hydroxylase Domain Proteins Promotes Therapeutic Revascularization
Loinard, C., Ginouvès, A., Vilar, J., Cochain, C., Zouggari, Y., Récalde, A., Duriez, M., Levy, B. I., Pouysségur, J., Berra, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.813303 · Cited by 84
Self-citation
Targeting the Warburg Effect That Arises in Tumor Cells Expressing Membrane Type-1 Matrix Metalloproteinase
Sakamoto, T., Niiya, D., & Seiki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188714 · Cited by 84
Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect
Seo, M., Kim, J., Neau, D. B., Sehgal, I., & Lee, Y. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024179 · Cited by 80
Suppression of T-cell responses by tumor metabolites
Singer, K., Gottfried, E., Kreutz, M. P., & Mackensen, A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0967-1 · Cited by 84
pH regulators in invadosomal functioning: Proton delivery for matrix tasting
Brisson, L., Reshkin, S. J., Goré, J., & Roger, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.04.004 · Cited by 88
The Low-Density Lipoprotein Receptor–Related Protein Regulates Cancer Cell Survival and Metastasis Development
Montel, V., Gaultier, A., Lester, R. D., Campana, W. M., & Gonias, S. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0683 · Cited by 83
The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis
Li, H., Xu, F., Li, S., Zhong, A., Meng, X., & Lai, M. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129481 · Cited by 85
On-target Inhibition of Tumor Fermentative Glycolysis as Visualized by Hyperpolarized Pyruvate
Seth, P., Grant, A. K., Tang, J., Vinogradov, E., Wang, X., Lenkinski, R. E., & Sukhatme, V. P. (2011) · Neoplasia · doi:10.1593/neo.101020 · Cited by 81
Redox homeostasis protects mitochondria through accelerating ROS conversion to enhance hypoxia resistance in cancer cells
Li, P., Zhang, D., Shen, L., Dong, K., Wu, M., Ou, Z., & Shi, D. (2016) · Scientific Reports · doi:10.1038/srep22831 · Cited by 84
Increased expression of histone demethylase JHDM1D under nutrient starvation suppresses tumor growth via down-regulating angiogenesis
Osawa, T., Muramatsu, M., Wang, F., Tsuchida, R., Kodama, T., Minami, T., & Shibuya, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108462109 · Cited by 81
Induction of SENP1 in Endothelial Cells Contributes to Hypoxia-driven VEGF Expression and Angiogenesis
Xu, Y., Zuo, Y., Zhang, H., Kang, X., Fei, Y., Yi, Z., Liu, M., Yeh, E. T. H., Chen, G., & Cheng, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164236 · Cited by 81
Systems oncology: Towards patient-specific treatment regimes informed by multiscale mathematical modelling
Powathil, G., Swat, M., & Chaplain, M. A. J. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.003 · Cited by 80
RETRACTED ARTICLE: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
Crociani, O., Zanieri, F., Pillozzi, S., Lastraioli, E., Stefanini, M., Fiore, A., Fortunato, A., D’Amico, M., Masselli, M., Lorenzo, E. D., et al. (2013) · Scientific Reports · doi:10.1038/srep03308 · Cited by 78
Retracted
RETRACTED ARTICLE: Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1α
Cascio, S., Bartella, V., Auriemma, A., Johannes, G. J., Russo, A. D., Giordano, A., & Surmacz, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210660 · Cited by 79
Retracted
REST is a hypoxia-responsive transcriptional repressor
Cavadas, M. A. S., Mesnieres, M., Crifò, B., Manresa, M. C., Selfridge, A. C., Keogh, C. E., Fábián, Z., Scholz, C. C., Nolan, K. A., Rocha, L. M. A., et al. (2016) · Scientific Reports · doi:10.1038/srep31355 · Cited by 81
Cell cycle and cell death in disease: past, present and future
Zhivotovsky, B., & Orrenius, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02282.x · Cited by 81
Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells
Ullmann, P., Nurmik, M., Begaj, R., Haan, S., & Letellier, E. (2019) · Cells · doi:10.3390/cells8060528 · Cited by 77
Activation of Peroxisome Proliferator-activated Receptor α (PPARα) Suppresses Hypoxia-inducible Factor-1α (HIF-1α) Signaling in Cancer Cells
Zhou, J., Zhang, S., Xue, J., Avery, J. E., Wu, J., Lind, S. E., & Ding, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367367 · Cited by 77
Turning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance
Seebacher, N. A., Lane, D. J. R., Richardson, D. R., & Jansson, P. J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.201 · Cited by 77
Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration
Gao, H.-J., Zhao, M.-C., Zhang, Y., Zhou, D.-S., Xu, L., Li, G., Chen, M.-S., & Liu, J. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1888-8 · Cited by 76
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Cai, Q., Verma, S. C., Kumar, P., Ma, M., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009720 · Cited by 76
Vaccinia-Related Kinase 2 Modulates the Stress Response to Hypoxia Mediated by TAK1
Blanco, S., Santos, C. R., & Lazo, P. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00025-07 · Cited by 76
Poly(ADP-Ribose) Polymerase 1 Promotes Tumor Cell Survival by Coactivating Hypoxia-Inducible Factor-1–Dependent Gene Expression
Elser, M., Borsig, L., Hassa, P. O., Erener, S., Messner, S., Valovka, T., Keller, S., Gassmann, M., & Hottiger, M. O. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0377 · Cited by 78
Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer
Yu, Y. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i33.9717 · Cited by 78
Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export
Parks, S. K., Cormerais, Y., Marchiq, I., & Pouysségur, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.001 · Cited by 80
Self-citation
Tumor Microenvironment Modulation Platform Based on Composite Biodegradable Bismuth–Manganese Radiosensitizer for Inhibiting Radioresistant Hypoxic Tumors
Liu, J., Zhang, J., Song, K., Du, J., Wang, X., Liu, J., Li, B., Ouyang, R., Miao, Y., Sun, Y., et al. (2021) · Small · doi:10.1002/smll.202101015 · Cited by 76
Engineering an Inward Proton Transport from a Bacterial Sensor Rhodopsin
Kawanabe, A., Furutani, Y., Jung, K., & Kandori, H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904855g · Cited by 75
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Benito, J., Ramirez, M. S., Zacharias, N. M., Vélez, J., Harutyunyan, K. G., Lu, H., Shi, Y.-X., Matre, P. R., Jacamo, R. O., Ma, H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3378 · Cited by 79
The role of hypoxia on prostate cancer progression and metastasis
Mohamed, O. A. A., Tesen, H. S., Hany, M., Sherif, A., Abdelwahab, M. M., & Elnaggar, M. H. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08251-5 · Cited by 81
Transcriptional Regulation of Urokinase-type Plasminogen Activator Receptor by Hypoxia-Inducible Factor 1 Is Crucial for Invasion of Pancreatic and Liver Cancer
Büchler, P., Reber, H. A., Tomlinson, J. S., Hankinson, O., Kallifatidis, G., Frieß, H., Herr, I., & Hines, O. J. (2009) · Neoplasia · doi:10.1593/neo.08734 · Cited by 75
Immune surveillance of human cancer: if the cytotoxic T‐lymphocytes play the music, does the tumoral system call the tune?
Hamaï, A., Benlalam, H., Meslin, F., Hasmim, M., Carré, T., Akalay, I., Janji, B., Berchem, G., Noman, M. Z., & Chouaı̈b, S. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01401.x · Cited by 77
Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis
Bordoli, M. R., Stiehl, D. P., Borsig, L., Kristiansen, G., Hausladen, S., Schraml, P., Wenger, R. H., & Camenisch, G. (2010) · Oncogene · doi:10.1038/onc.2010.433 · Cited by 78
Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis
Doyen, J., Parks, S. K., Marcié, S., Pouysségur, J., & Chiche, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2012.00199 · Cited by 71
Self-citation
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Ward, C., Meehan, J., Gray, M., Kunkler, I. H., Langdon, S. P., & Argyle, D. J. (2018) · Metabolites · doi:10.3390/metabo8010013 · Cited by 76
Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
Valle‐Mendiola, A., & Soto‐Cruz, I. (2020) · Cancers · doi:10.3390/cancers12010124 · Cited by 73
PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
Su, Y. Y., Loos, M., Giese, N. A., Hines, O. J., Diebold, I., Görlach, A., Metzen, E., Pastoreková, S., Frieß, H., & Büchler, P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605936 · Cited by 70
Notch signaling induces EMT in OSCC cell lines in a hypoxic environment
Ishida, T., Hijioka, H., Kume, K., Miyawaki, A., & Nakamura, N. (2013) · Oncology Letters · doi:10.3892/ol.2013.1549 · Cited by 73
Metabolic function inDrosophila melanogasterin response to hypoxia and pure oxygen
Voorhies, W. A. V. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.031179 · Cited by 73
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer
Wei, T.-T., Lin, Y., Tang, S.-P., Luo, C.-K., Tsai, C.-C., Shun, C., & Chen, C. (2019) · Oncogene · doi:10.1038/s41388-019-0999-8 · Cited by 73
A pH-sensitive nanocarrier based on BSA-stabilized graphene-chitosan nanocomposite for sustained and prolonged release of anticancer agents
Gooneh-Farahani, S., Naghib, S. M., Naimi‐Jamal, M. R., & Seyfoori, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-97081-1 · Cited by 72
The Hypoxia-Inducible Factor 1/NOR-1 Axis Regulates the Survival Response of Endothelial Cells to Hypoxia
Martorell, L., Gentile, M., Rius, J., Rodrı́guez, C., Crespo, J., Badimón, L., & Martínez‐González, J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00945-09 · Cited by 73
Targeting pH regulating proteins for cancer therapy–Progress and limitations
Parks, S. K., & Pouysségur, J. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.007 · Cited by 71
Self-citation
Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers
Kunchithapautham, K., & Rohrer, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214593 · Cited by 71
Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症：英文版 · doi:10.1186/s40880-017-0202-y · Cited by 76
Fetal Growth Plate
Provot, S., & Schipani, E. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.076 · Cited by 72
Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids
Souleimanian, N. E., Deleavey, G. F., Soifer, H. S., Wang, S., Tiemann, K., Damha, M. J., & Stein, C. A. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.35 · Cited by 71

Authors: Pouysségur, J., Dayan, F., & Mazure, N. M.
Affiliations: Centre National de la Recherche Scientifique (FR)
Corresponding author: Pouysségur, Jacques
ORCID: Pouysségur, Jacques
Mazure, Nathalie M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2006-05-24
Volume: 441
Issue: 7092
Pages: 437-443
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature04871
OpenAlex: W2082483448
Semantic Scholar: 5bbdcf74ee4cdf263a532b6dbae0b8dd5efb9722
Cited by: 1,676
References: 104
Citations by year: 2026: 19 · 2025: 39 · 2024: 48 · 2023: 75 · 2022: 85 · 2021: 97 · 2020: 87 · 2019: 77 · 2018: 81 · 2017: 68 · 2016: 85 · 2015: 80 · 2014: 103 · 2013: 104 · 2012: 89
FWCI: 6.91
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Ligue Contre le Cancer
Centre National de la Recherche Scientifique
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
Keywords: hypoxia signaling, hypoxia-inducible factor, tumor hypoxia, tumor regression, cancer metabolism, intracellular pH regulation, tumor angiogenesis, glucose metabolism, necrosis, autophagy, cell invasion, cancer therapy, tumor oxygenation
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Oxygen, Protein Kinases, Signal Transduction, Cell Hypoxia, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia signalling in cancer and approaches to enforce tumour regression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks